Lockheed Martin Investment Management Co. reduced its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 31.2% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,600 shares of the medical equipment provider’s stock after selling 4,810 shares during the period. Lockheed Martin Investment Management Co.’s holdings in Intuitive Surgical were worth $4,310,000 at the end of the most recent quarter.
Other institutional investors have also added to or reduced their stakes in the company. North Point Portfolio Managers Corp OH purchased a new stake in Intuitive Surgical in the third quarter worth about $27,000. John Boyer Inc. bought a new position in shares of Intuitive Surgical in the third quarter worth about $27,000. Compass Wealth Management LLC purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $29,000. Main Street Group LTD purchased a new position in shares of Intuitive Surgical during the 1st quarter valued at about $30,000. Finally, Compass Financial Management LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter valued at about $30,000. 83.64% of the stock is currently owned by institutional investors.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, Director Craig Barratt sold 1,150 shares of the company’s stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $460.00, for a total transaction of $529,000.00. Following the sale, the director directly owned 1,150 shares in the company, valued at $529,000. This represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Guthart sold 10,000 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total value of $4,573,400.00. Following the completion of the transaction, the director owned 1,194,530 shares of the company’s stock, valued at approximately $546,306,350.20. This trade represents a 0.83% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 39,056 shares of company stock valued at $17,585,864. Corporate insiders own 0.60% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have commented on ISRG. Citigroup decreased their target price on shares of Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. Leerink Partners set a $503.00 price objective on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 21st. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. Finally, Mizuho lowered their target price on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a research note on Wednesday, October 21st. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $493.54.
Read Our Latest Analysis on ISRG
Intuitive Surgical Stock Up 1.7%
Intuitive Surgical stock opened at $460.56 on Tuesday. The company’s 50-day moving average price is $411.69 and its 200-day moving average price is $431.58. The company has a market cap of $159.65 billion, a PE ratio of 55.69, a price-to-earnings-growth ratio of 3.32 and a beta of 1.45. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same quarter last year, the firm earned $2.40 EPS. As a group, sell-side analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.
Key Stories Impacting Intuitive Surgical
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Revenue grew 22%, and the company placed 546 da Vinci systems in the third quarter of 2026. The article notes that system placements support a larger installed base, while instruments and services generate much of Intuitive Surgical’s recurring revenue. Intuitive Surgical Placed 546 da Vinci Systems Last Quarter. Why Wall Street’s Sell-Off Misses the Point.
- Positive Sentiment: Robust procedure growth and adoption of the da Vinci 5 system have helped shares recover, according to a six-month review. ISRG Gains 7.8% in 6 Months: Will the Share Price Recovery Continue?
- Neutral Sentiment: Intuitive Surgical appeared on a published list of top healthcare stocks following the midterm elections. The inclusion reflects investor interest in the sector, but is not a company-specific business development. Why Intuitive Surgical (ISRG) Just Cracked the Top 10 Best Healthcare Stocks List
- Negative Sentiment: Growing competition, litigation costs and valuation concerns could weigh on the shares. One article also notes that ISRG remains down for the year despite strong revenue growth. Intuitive Surgical (ISRG) Just Grew Revenue 22%. Why Is the Stock Still Down This Year?
Intuitive Surgical Company Profile
Recommended Stories
- Five stocks we like better than Intuitive Surgical
- Wall Street May Be Making a Big Mistake With monday.com Stock
- Are These 2 Mid-Cap Growth Stocks Worth the Risk?
- Oklo Changes the Narrative: Does a Nuclear Stock Price Explosion Come Next?
- Cloudflare’s 20% Sell-Off May Have Created an Opening for Investors
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
